TrialHub, a leading data intelligence platform for clinical trial strategists, is proud to announce the launch of TrialHub IQ, a revolutionary AI-powered chat for the clinical research industry. This innovative feature equips professionals with unparalleled access to a vast repository of medical knowledge, providing the industry with a game-changing tool for precision planning and patient-centric trial strategies.
TrialHub IQ leverages cutting-edge artificial intelligence to query 20 million PubMed articles and over 2000 medical guidelines within a matter of seconds. This significant advancement empowers Contract Research Organizations (CROs) and Pharmaceutical companies to redefine their approach to clinical trial planning.
The clinical research industry has long been challenged when it comes to obtaining accurate quantitative as well as qualitative patient insights. TrialHub IQ eliminates this hurdle by offering a comprehensive 360° overview of the landscape derived from extensive medical literature. This powerful tool builds upon TrialHub’s capabilities and vast database that includes standard of care insights and enables professionals to go beyond traditional country and site assessment to perform patient feasibility.
Some of the key features of TrialHub IQ include:
Instant Access to Vast Medical Knowledge: TrialHub IQ enables users to instantly access a wealth of medical knowledge, unlocking insights that were previously hard to obtain.
Precision Planning: CROs and Pharma companies can now plan clinical trials with unprecedented precision, based on accurate predictions and patient-centric considerations.
Effortless Search: With TrialHub IQ, users can initiate searches without the need to enter specific indications. Instead, they can search by investigator, site, or across therapeutic areas, streamlining the feasibility assessment process.
Proprietary Data: Companies with a database of patient insights collected over the years can now securely upload the tons of documents at their disposal and query them in seconds along with the millions of TrialHub sources, gaining access to unique data only available to them.
TrialHub is committed to empowering clinical trial strategists with the tools they need to plan the clinical trials of tomorrow. The launch of TrialHub IQ marks a significant milestone in advancing patient-centric clinical research.
"We believe that TrialHub IQ will transform the way clinical trials are planned and executed," said Maya Zlatanova, CEO at TrialHub. "By providing quick access to a vast array of medical knowledge, we are enabling our clients to make informed decisions that will positively impact patients and streamline the drug development process."
TrialHub IQ is now available to TrialHub users, further solidifying TrialHub's position as a leader in clinical trial data intelligence.
TrialHub is a knowledge hub powered by cutting-edge AI technologies that helps clinical research and medical professionals gain access to millions of validated data sources in the form of insights to make data-driven, patient-centric decisions. For more information, visit trialhub.com.